Tower Research Capital LLC (TRC) - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$80,000
-3.6%
2,348
-34.2%
0.00%
+100.0%
Q1 2021$83,000
-47.1%
3,566
-34.7%
0.00%
-80.0%
Q4 2020$157,000
+201.9%
5,459
+114.7%
0.01%
+400.0%
Q3 2020$52,000
-71.6%
2,543
-58.3%
0.00%
-87.5%
Q2 2020$183,000
+6000.0%
6,096
+5996.0%
0.01%
Q1 2020$3,000
+50.0%
100
-39.8%
0.00%
Q2 2019$2,000
-84.6%
166
-83.1%
0.00%
-100.0%
Q1 2019$13,000985
+1463.5%
0.00%
Q4 2018$0
-100.0%
63
-94.2%
0.00%
-100.0%
Q3 2018$7,0001,0900.00%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders